Patents
Patents for C07K 4 - Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof (2,102)
03/1996
03/27/1996EP0593506B1 Lipoaminoacids, preparation method and applications
03/06/1996EP0416033B1 Macrocyclic chelates and methods of use thereof
02/1996
02/28/1996EP0697884A1 Ligand precursors for incorporation into peptides
02/13/1996US5491073 Cloning of chicken anaemia DNA
02/01/1996CA2195197A1 Corticotropin-releasing factor-binding-protein inhibitors and their use
01/1996
01/09/1996US5482723 Streptococcus bacteria for milk
01/03/1996EP0317622B1 Prevention and treatment of retroviral disease
12/1995
12/13/1995EP0686161A1 NOVEL HUMAN $g(b) 2? INTEGRIN ALPHA SUBUNIT
12/06/1995EP0685236A1 Prevention and treatment of retroviral disease
11/1995
11/28/1995US5470953 Human β2 integrin α subunit
11/23/1995WO1995031474A1 Compounds for reversing drug resistance
11/08/1995CN1111158A Products containing G-CSF and TNF binding protein
10/1995
10/10/1995US5456910 Antibiotic stalobacins
09/1995
09/27/1995EP0673234A1 Tissue protective and regenerative compositions
09/20/1995EP0672683A1 Macif protein, genes coding therefor, expression vectors containing said genes, and transformant cells containing said protein
09/19/1995US5451570 Glycopeptide antibiotic, useful against methicillin resistant S. aureus strains
09/08/1995WO1995023812A1 Antibiotic stalobacins
09/08/1995CA2183951A1 Antibiotic stalobacins
08/1995
08/23/1995EP0668077A1 Compositions containing G-CSF and TNF binding protein
08/22/1995US5443986 Enzymatic analysis using substrates that yield fluorescent precipitates
08/22/1995US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis
08/02/1995CN1106020A Synthetic method of casein iodide
07/1995
07/25/1995CA1336407C Prevention and treatment of retroviral disease
07/12/1995EP0662135A1 Alteration of polypeptides.
07/11/1995US5432202 Use of polyamines as ionic-channel regulating agents
07/11/1995CA1336307C Process for the preparation of a heat resistant non bitter water-soluble peptide, the product produced by the process, and nutrients, refreshments and dietetics comprising the product
06/1995
06/29/1995WO1995017412A1 NOVEL HUMAN β2 INTEGRIN ALPHA SUBUNIT
06/29/1995CA2156622A1 Novel human .beta.2 integrin alpha subunit
06/27/1995US5428154 Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions
06/27/1995US5427925 Recombniant method for making leukemia inhibitor factor
06/14/1995EP0656946A1 Immunoglobulins devoid of light chains
05/1995
05/31/1995CN1103068A Amino-acid low peptide preparing method
05/24/1995EP0574394B1 Substances of polypeptide nature useful in human therapy
05/16/1995US5415859 Production and use of antheimintic agents and protective antigens
04/1995
04/25/1995US5409990 Useful for replacement therapy in patient suffering from hemophilia B
03/1995
03/29/1995EP0644932A1 Purified forms of dnase
03/21/1995US5399550 Physiologically active substance derived or malt and process for the production thereof
03/16/1995WO1995007354A1 Peptides that elicit neutralizing antibodies against genetically divergent hiv-1 strains
03/15/1995EP0642532A1 Proteinoid carriers and methods for preparation and use thereof
03/09/1995WO1995006662A1 Neuron regulatory factor for promoting neuron survival
03/09/1995CA2170751A1 Neuron regulatory factor for promoting neuron survival
03/08/1995EP0641351A1 Enzymatic analysis using substrates that yield fluorescent precipitates.
03/01/1995EP0640101A1 Methods and reagents for diagnosis of autoantibodies
01/1995
01/17/1995US5382431 Administering a heat stable peptone digest complexed with an ionic transition metal to accelerate healing of topical wounds in mammals
11/1994
11/30/1994EP0626452A1 Vaccine against Streptococcus suis infection
11/24/1994WO1994026294A1 Ligand precursors for incorporation into peptides
11/15/1994US5364624 Inhibitors of human leukocyte elastase, treatment of cystic fibrosis
11/02/1994EP0621868A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
10/1994
10/18/1994US5356794 Purified enzymatic preparation derived from chromobacterium violaceum, method for preparing it and its use in the production of α, β-dehydrotryptophanyl-peptides
10/18/1994CA1332650C Polysaccharides and antiviral drugs containing the same as active ingredient
08/1994
08/25/1994DE4405249A1 Stabilisierte Troponin-Zubereitung für Immunoassays und Verfahren zur Stabilisierung von Troponin für Immunoassays Stabilised troponin composition for immunoassays and method for stabilizing Troponin in immunoassays
08/25/1994DE4305351A1 Aurantimycin, peptide antibiotic from Streptomyces aurantiacus, and chemical derivatives with pharmacological action, a process for the preparation and the use thereof
08/16/1994US5338682 Starters for fermented foods which also suppress acid formation in milk during storage or transportation
08/04/1994WO1993025583A3 Proteinoid carriers and methods for preparation and use thereof
07/1994
07/13/1994EP0309483B1 Production and use of anthelmintic agents and protective antigens
06/1994
06/30/1994DE4244415A1 Peptide prepn contg e g, tri:peptide(s) Gly-His-Lys and/or Gly-Asp-Ser
06/29/1994EP0514416B1 Bacterial peptide fraction with an immunostimulatory effect, process for making it and its use
06/22/1994EP0602761A1 Prevention and treatment of retroviral disease
06/15/1994EP0600866A1 Compositions and methods for identifying biologically active molecules
06/01/1994EP0479912B1 Inhibition of the n-end rule pathway in living cells
06/01/1994EP0250501B2 A process for the preparation of a heat resistant non-bitter water-soluble peptide product, the product produced by the process, and nutrients, refreshments and dietetics comprising the product
05/1994
05/31/1994US5316906 Fluorescent dyes for substrates
05/24/1994US5314873 Milk-protein hydrolyzates and compositions for use as hair and skin treating agent
05/17/1994US5312809 Physiologically active substance derived from malt and process for the production thereof
04/1994
04/14/1994WO1994008018A1 Alteration of polypeptides
04/14/1994WO1994007448A1 Tissue protective and regenerative compositions
04/13/1994EP0591431A1 Hepatitis c virus (hcv) polypeptides
03/1994
03/08/1994US5292510 WS7622A mono- or di- sulfate, process for preparation thereof and use thereof
03/03/1994WO1994004678A1 Immunoglobulins devoid of light chains
03/02/1994EP0585042A1 Antibiotic stalobacins
02/1994
02/26/1994CA2104847A1 Antibiotic stalobacins
01/1994
01/25/1994US5281661 Contacting aqueous conductive mixture with carrier based on a polymer containing hydrophobic groups to complex factor XI
01/18/1994US5279826 Prophylactic/therapeutic composition for disseminated intravascular coagulation, chronic respiratory tract infectious disease or chronic bronchitis
01/18/1994US5279823 Purified forms of DNASE
12/1993
12/23/1993WO1993025670A1 Purified forms of dnase
12/23/1993WO1993025583A2 Proteinoid carriers and methods for preparation and use thereof
12/23/1993CA2138146A1 Proteinoid carriers and methods for preparation and use thereof
11/1993
11/02/1993CA1323851C Expression of human proapolipoprotein a-i
10/1993
10/28/1993WO1993021223A1 Methods and reagents for diagnosis of autoantibodies
09/1993
09/23/1993DE4208923A1 Antirheumatic and antiinflammatory agent - comprising mixt. cpds. contg. aminoacid(s), isolated from bacteria or plants, esp. Helleborus, with long lasting action at low doses
09/21/1993US5246715 Platelet-aggregating inhibitory agents from leech saliva and pharmaceutical preparations containing the same
09/16/1993WO1993016087A3 Amadori reaction compounds and products, process for their manufacture, and their use
09/14/1993US5244577 Process for preparing osteogenesis promoting substance
09/07/1993US5242947 Use of polyamines as ionic-channel regulating agents
08/1993
08/31/1993US5240842 Penetration of living cells by particles
08/19/1993WO1993016087A2 Amadori reaction compounds and products, process for their manufacture, and their use
08/19/1993CA2130106A1 Amadori reaction compounds and products, process for their manufacture, and their use
07/1993
07/08/1993WO1993013127A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
07/08/1993WO1993012777A1 Use of polyamines as ionic-channel regulating agents
07/08/1993CA2126693A1 Peptides immunochemically reactive with antibodies directed against hepatitis non-a, non-b virus
06/1993
06/30/1993EP0548234A1 Cloning of chicken anaemia dna
05/1993
05/25/1993US5213797 Excellent activity against grampositive bacteria; increased feed-utilization efficiency and improved weight gains in animals
04/1993
04/29/1993WO1993000365A3 Hepatitis c virus (hcv) polypeptides
03/1993
03/10/1993EP0531204A1 Purified enzymatic preparation from chromobacterium violaceum, process to obtain it and its use in the production of alpha, beta-dehydrotryptophanyl peptides
03/09/1993US5192742 Antibiotics
03/04/1993WO1993004077A1 Enzymatic analysis using substrates that yield fluorescent precipitates
02/1993
02/18/1993WO1993002708A1 Novel reagent for tumour imaging and therapy
02/16/1993US5187077 Leukaemia inhibitory factor
02/10/1993EP0527056A1 Novel reagent for tumour imaging and therapy
01/1993
01/07/1993WO1993000365A2 Hepatitis c virus (hcv) polypeptides
1 ... 10 11 12 13 14 15 16 17 18 19 20 21 22